share_log

Processa Pharmaceuticals | 8-K: Current report

Processa Pharmaceuticals | 8-K:重大事件

美股sec公告 ·  02/22 06:32
牛牛AI助理已提取核心訊息
On February 20, 2024, Processa Pharmaceuticals, Inc. CEO George Ng presented at the Winter Wrap-Up MicroCap Rodeo Conference. The company, listed on the Nasdaq Capital Market under the trading symbol PCSA, is based in Hanover, Maryland, and is incorporated in Delaware. Processa has provided the presentation materials as Exhibit 99.1, which are also accessible to investors on the company's website. While Processa has no obligation to update the information presented, it may do so in the future through various public disclosure methods. The information disclosed in the presentation and the report is not considered filed under the Securities and Exchange Act of 1934 and is not subject to its liabilities, nor is it incorporated by reference into any filings under the Securities Act of 1933, unless specifically referenced.
On February 20, 2024, Processa Pharmaceuticals, Inc. CEO George Ng presented at the Winter Wrap-Up MicroCap Rodeo Conference. The company, listed on the Nasdaq Capital Market under the trading symbol PCSA, is based in Hanover, Maryland, and is incorporated in Delaware. Processa has provided the presentation materials as Exhibit 99.1, which are also accessible to investors on the company's website. While Processa has no obligation to update the information presented, it may do so in the future through various public disclosure methods. The information disclosed in the presentation and the report is not considered filed under the Securities and Exchange Act of 1934 and is not subject to its liabilities, nor is it incorporated by reference into any filings under the Securities Act of 1933, unless specifically referenced.
2024年2月20日,Processa Pharmicals, Inc.首席執行官喬治·吳在冬季總結微型股牛仔競技大會上發表了演講。該公司在納斯達克資本市場上市,交易代碼爲PCSA,總部位於馬里蘭州漢諾威,在特拉華州註冊成立。Processa以附錄99.1的形式提供了演示材料,投資者也可以在該公司的網站上查閱。儘管Processa沒有義務更新所提供的信息,但將來可能會通過各種公開披露方法進行更新。除非特別提及,否則陳述和報告中披露的信息不被視爲根據1934年《證券交易法》提交的信息,也不受其責任約束,也不會以引用方式納入根據1933年《證券法》提交的任何文件中。
2024年2月20日,Processa Pharmicals, Inc.首席執行官喬治·吳在冬季總結微型股牛仔競技大會上發表了演講。該公司在納斯達克資本市場上市,交易代碼爲PCSA,總部位於馬里蘭州漢諾威,在特拉華州註冊成立。Processa以附錄99.1的形式提供了演示材料,投資者也可以在該公司的網站上查閱。儘管Processa沒有義務更新所提供的信息,但將來可能會通過各種公開披露方法進行更新。除非特別提及,否則陳述和報告中披露的信息不被視爲根據1934年《證券交易法》提交的信息,也不受其責任約束,也不會以引用方式納入根據1933年《證券法》提交的任何文件中。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。